Holen Sie sich die Stockscreener-App
31.10
2.72%
-0.91
Schlusskurs vom Vortag:
$32.01
Offen:
$31.6
24-Stunden-Volumen:
117.87K
Relative Volume:
0.22
Marktkapitalisierung:
$1.59B
Einnahmen:
$447.57M
Nettoeinkommen (Verlust:
$-38.92M
KGV:
-37.47
EPS:
-0.83
Netto-Cashflow:
$-1.15M
1W Leistung:
-4.54%
1M Leistung:
-7.16%
6M Leistung:
+9.11%
1J Leistung:
+34.22%
1-Tages-Spanne:
$30.78
$31.60
1-Wochen-Bereich:
$30.78
$33.55
52-Wochen-Spanne:
$18.94
$43.11
Atricure Inc Stock (ATRC) Company Profile
Firmenname
Atricure Inc
Sektor
Telefon
513-755-4100
Adresse
7555 INNOVATION WAY, MASON, OH
Vergleichen Sie ATRC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
31.11 | 1.59B | 447.57M | -38.92M | -1.15M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
464.50 | 175.60B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
194.32 | 59.07B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
90.95 | 44.80B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
209.64 | 31.51B | 4.93B | 1.25B | 1.38B | 8.47 |
|
COO
The Cooper Companies, Inc.
|
78.64 | 15.83B | 3.90B | 392.30M | 288.10M | 1.95 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-04-23 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2021-08-05 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Bestätigt | Needham | Buy |
| 2020-11-06 | Bestätigt | Needham | Buy |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-24 | Bestätigt | Needham | Buy |
| 2019-08-13 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-04 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-08-02 | Bestätigt | Stifel | Buy |
| 2018-06-18 | Bestätigt | Needham | Buy |
| 2018-04-27 | Bestätigt | Needham | Buy |
| 2018-01-16 | Bestätigt | Needham | Buy |
| 2017-11-02 | Bestätigt | Needham | Buy |
| 2017-07-28 | Bestätigt | Needham | Buy |
| 2017-05-30 | Fortgesetzt | Piper Jaffray | Overweight |
| 2016-06-30 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2015-10-28 | Bestätigt | Needham | Buy |
| 2015-10-06 | Bestätigt | Canaccord Genuity | Buy |
| 2015-10-06 | Bestätigt | Needham | Buy |
Alle ansehen
Atricure Inc Aktie (ATRC) Neueste Nachrichten
Cryoablation Market Set to Witness Significant Growth by 2032 | - openPR.com
AtriCure Announces First Use of the AtriClip PRO-Mini® Device | - GuruFocus
AtriCure launches smaller device for heart surgery By Investing.com - Investing.com South Africa
AtriCure announces first use of newest AtriClip device - MassDevice
AtriCure Reports 1st Use of Newest AtriClip LAA Exclusion System - Medical Product Outsourcing
AtriCure launches smaller device for heart surgery - Investing.com Australia
AtriCure Announces First Use of the AtriClip PRO-Mini® Device - Yahoo Finance
Groundbreaking Miniature Cardiac Device Transforms LAA Management: AtriClip PRO-Mini Debuts - Stock Titan
Dayton’s stocks continue loss streak following election and now tariffs - The Business Journals
AtriCure Drops 25%: Bargain Or Caution Sign? (NASDAQ:ATRC) - Seeking Alpha
AtriCure to Announce First Quarter 2025 Financial Results - MarketScreener
Is AtriCure (NASDAQ:ATRC) A Risky Investment? - simplywall.st
JMP maintains AtriCure stock with $60 target post-Investor Day By Investing.com - Investing.com Canada
When the Price of (ATRC) Talks, People Listen - news.stocktradersdaily.com
Canaccord Genuity Adjusts Price Target on AtriCure to $52 From $66, Maintains Buy Rating - MarketScreener
Oppenheimer maintains AtriCure stock Outperform rating, $45 target By Investing.com - Investing.com Australia
UBS maintains Buy on AtriCure stock, reiterates $60 target By Investing.com - Investing.com Australia
UBS maintains Buy on AtriCure stock, reiterates $60 target - Investing.com
Piper Sandler maintains $50 target on AtriCure stock, cites growth By Investing.com - Investing.com Canada
Piper Sandler maintains $50 target on AtriCure stock, cites growth - Investing.com
Needham maintains Buy on AtriCure stock, $51 target By Investing.com - Investing.com Australia
Needham maintains Buy on AtriCure stock, $51 target - Investing.com
Oppenheimer maintains AtriCure stock Outperform rating, $45 target - Investing.com
BTIG raises AtriCure stock price target to $58, maintains buy By Investing.com - Investing.com South Africa
BTIG raises AtriCure stock price target to $58, maintains buy - Investing.com
AtriCure Highlights Growth and Innovation at Investor Day - TipRanks
Electrophysiology Devices Market Poised for Strong Growth, Projected to Expand at a 9.73% CAGR by 2030, Reports DelveInsight - Barchart.com
Needham maintains AtriCure stock Buy rating, $51 target By Investing.com - Investing.com Canada
11 Analysts Have This To Say About AtriCure - Benzinga
Needham maintains AtriCure stock Buy rating, $51 target - Investing.com India
(ATRC) Investment Analysis - news.stocktradersdaily.com
AtriCure to Host Analyst & Investor Day on March 26, 2025 - Yahoo Finance
AtriCure Investor Day: New Product Pipeline and Financial Targets Coming March 2025 - Stock Titan
AtriCure, Inc. to Host Earnings Call - ACCESS Newswire
AtriCure Independent Director Karen Prange Sells 25% Of Holding - Simply Wall St
(ATRC) Long Term Investment Analysis - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Stock Price Down 6% Following Insider Selling - Defense World
Atricure director Karen Prange sells $232,531 in stock By Investing.com - Investing.com Canada
Atricure Director Makes a Significant Stock Sale! - TipRanks
Finanzdaten der Atricure Inc-Aktie (ATRC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.66%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):